These results supported the further development and evaluation of SCB-1019 in combination with the PreF-Trimer antigens for hMPV and PIV3, which are also utilizing the Trimer-Tag platform.

These results supported the further development and evaluation of SCB-1019 in combination with the PreF-Trimer antigens for hMPV and PIV3, which are also utilizing the Trimer-Tag platform.

These results supported the further development and evaluation of SCB-1019 in combination with the PreF-Trimer antigens for hMPV and PIV3, which are also utilizing the Trimer-Tag platform.

"We are pleased to announce the Phase I clinical trial initiation of our potential first-in-class combination vaccine candidates SCB-1022 (RSV+hMPV) and SCB-1033 (RSV+hMPV+PIV3), further demonstrating ...

hVIVO plc (AIM: HVO), a fast-growing early-stage Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that, following the success of its pilot human ...

China’s HMPV cases were ‘within the expected range’, according to the WHO. But that hasn’t stopped the falsehoods and fearmongering.

HMPV, or human metapneumovirus, is a respiratory virus that primarily causes upper and lower respiratory infections. It's most common in young children, older adults and immunocompromised individuals.

The graph above shows the weekly percentage of HMPV-positive tests, as reported to the National Respiratory and Enteric Virus Surveillance System, updated on Jan. 13, 2025. (CDC) Since fall, most ...

A recent study has identified new lineages of human metapneumovirus (hMPV) — A2.2.1 and A2.2.2, highlighting its significant prevalence among children ...

Others comment, “Increasing cases of HMPV Metapneumovirus Infections among humans have been reported in China” and, “China declares a state of emergency as a surge of multiple viruses ...